Although it was thought that an increase in the number of ACE2, caused by ACE inhibitors and angiotensin receptor blockers (ARB), increases susceptibility to the infection, large groups of investigators found no link between these medications and risks of infection or in-hospital mortality. The gene discussed is ACE2; the disease is infection.